Individualised cognitive behaviour therapy in patients of substance use disorders: three case studies

Shahzadi, Mafia; Abbas, Qasir

doi:10.47391/jpma.405

Cited by 6 publications

(8 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Based on the reported effectiveness of CBT in the treatment of SUDs [1][2][3][4][5][6][7] and the factors, facilitators, barriers, and challenges affecting its use in Pakistan, an intervention framework was conceptualized in the present study to enhance its utilization in the Pakistani context. See Table 2 for details.…”

Section: Discussionmentioning

confidence: 99%

“…Cognitive behaviour therapy (CBT) has been reported to be one of the most effective psychological interventions for various psychological disorders, including anxiety disorders, depression, obsessive-compulsive disorder, bipolar disorder, and substance use disorders (SUDs) [1][2][3][4][5][6][7]. The basic assumption of CBT is that individuals' thought patterns and beliefs influence their feelings and behaviours [8,9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Experience of psychologists in the delivery of cognitive behaviour therapy in a non-western culture for treatment of substance abuse: a qualitative study

Azad

Khan

Ali

et al. 2022

Int J Ment Health Syst

View full text Add to dashboard Cite

Background Psychotherapy is the preferred form of treatment for psychological disorders worldwide. Cognitive behaviour therapy (CBT) is one of the most widely used psychotherapies due to its proven efficacy for psychological disorders, including substance abuse. However, CBT was developed in the West according to the culture of developed countries. Therefore, it requires cross-cultural adaptation for non-Western countries. Pakistan is one of the developing non-Western countries where substance use disorders are increasing at an alarming rate. Despite the proven efficacy of CBT for substance use disorders, there is a dearth of its utilization in Pakistan. Therefore, in the present study, in-depth qualitative interviews were conducted with CBT practitioners in Pakistan to understand barriers and challenges in this regard. The study was a part of a broader project aimed at cultural adaptation of CBT for people with substance use disorders (SUDs) in Pakistan. Methods In-depth qualitative interviews were conducted with CBT practitioners (N = 8) working in rehabilitation centres and hospitals in Islamabad, Pakistan. Thematic content analysis was conducted to develop core themes from the data. Results CBT for SUDs requires some adjustments according to Pakistani culture for successful utilization. The challenges in providing CBT for SUDs revolved around three main themes, i.e., the mental health system, societal practices, and therapeutic issues, and 10 subthemes. Conclusion In order to utilize the benefits of CBT for SUDs in Pakistan, cultural adaptation is necessary as an initial step. However, its delivery requires stringent modifications in the health care system to address these challenges.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Experience of psychologists in the delivery of cognitive behaviour therapy in a non-western culture for treatment of substance abuse: a qualitative study

Azad

Khan

Ali

et al. 2022

Int J Ment Health Syst

View full text Add to dashboard Cite

show abstract

“…Physical exercise has been associated with improved scores in the Marijuana Craving Questionnaire—short form (MCQ-SF) in a pilot study (n = 10) of non-treatment-seeking, cannabis-dependent adults [ 42 ]. Standard sleep hygiene protocols [ 43 ] and CBT-insomnia (CBT-I [ 44 ]) may improve sleep in cannabis withdrawal, but this has not been well studied [ 45 ].…”

Section: Gold-standard Current Practicementioning

confidence: 99%

Clinical management of cannabis withdrawal

Connor

Stjepanović

Budney³

et al. 2022

Addiction

View full text Add to dashboard Cite

Background and Aims Cannabis withdrawal is a well‐characterized phenomenon that occurs in approximately half of regular and dependent cannabis users after abrupt cessation or significant reductions in cannabis products that contain Δ9‐tetrahydrocannabinol (THC). This review describes the diagnosis, prevalence, course and management of cannabis withdrawal and highlights opportunities for future clinical research. Methods Narrative review of literature. Results Symptom onset typically occurs 24–48 hours after cessation and most symptoms generally peak at days 2–6, with some symptoms lasting up to 3 weeks or more in heavy cannabis users. The most common features of cannabis withdrawal are anxiety, irritability, anger or aggression, disturbed sleep/dreaming, depressed mood and loss of appetite. Less common physical symptoms include chills, headaches, physical tension, sweating and stomach pain. Despite limited empirical evidence, supportive counselling and psychoeducation are the first‐line approaches in the management of cannabis withdrawal. There are no medications currently approved specifically for medically assisted withdrawal (MAW). Medications have been used to manage short‐term symptoms (e.g. anxiety, sleep, nausea). A number of promising pharmacological agents have been examined in controlled trials, but these have been underpowered and positive findings not reliably replicated. Some (e.g. cannabis agonists) are used ‘off‐label’ in clinical practice. Inpatient admission for MAW may be clinically indicated for patients who have significant comorbid mental health disorders and polysubstance use to avoid severe complications. Conclusions The clinical significance of cannabis withdrawal is that its symptoms may precipitate relapse to cannabis use. Complicated withdrawal may occur in people with concurrent mental health and polysubstance use.

show abstract

“…Llama la atención que, pese a la evidencia comentada, en el presente estudio, solo 14 pacientes acudieron a recibir este tipo de tratamiento. (14) Respecto del tratamiento farmacológico, hay poca evidencia para orientar el manejo y esquemas específicos. En relación con esta variable es necesario realizar una evaluación caso a caso, considerando los elementos que confluyen en el paciente, tales como el tipo de sustancia consumida, patologías médicas o psiquiátricas comórbidas, disponibilidad de fármacos, entre otros.…”

Section: Variableunclassified

Consumo de sustancias: Caracterización de pacientes pertenecientes a la unidad de salud mental adultos- Hospital Hernán Henríquez Aravena.

B.¹,

M.²

2022

Rev. chil. neuro-psiquiatr.

View full text Add to dashboard Cite

Introduction: psychoactive substances have been part of the existence of humanity for thousands of years and have been used for different purposes, consolidating its use and abuse in recent years as a highly prevalent condition in our society. They are a large number of substances, and also various forms of classification. In terms of world prevalence, to date, there is no gold standard method that allows the exact measurement of substance consumption to each geographical region, which makes the study difficult and constitutes a challenge when making comparisons between regions. However, in terms of world prevalence, the most consumed substance is alcohol, followed by cannabis, opioids, amphetamines, and cocaine respectively. Objective: characterize adult patients of the mental health polyclinic of the Hernán Henríquez Aravena Hospital with a diagnosis related to substance use and establish the main substances consumed. Material and Method: A cross-sectional descriptive study was carried out in the target population by reviewing the clinical records of adult patients treated at the mental health polyclinic of the Hernán Henríquez Aravena Hospital, during the years 2018, 2019, and 2020. The antecedents collected from the study were analyzed according to the general population and compared according to gender. Results: In the sample studied, 73.2% of the users are male, alcohol being the substance most consumed, followed by cocaine, marijuana, and benzodiazepines

show abstract

Individualised cognitive behaviour therapy in patients of substance use disorders: three case studies

Cited by 6 publications

References 9 publications

Experience of psychologists in the delivery of cognitive behaviour therapy in a non-western culture for treatment of substance abuse: a qualitative study

Experience of psychologists in the delivery of cognitive behaviour therapy in a non-western culture for treatment of substance abuse: a qualitative study

Clinical management of cannabis withdrawal

Consumo de sustancias: Caracterización de pacientes pertenecientes a la unidad de salud mental adultos- Hospital Hernán Henríquez Aravena.

Contact Info

Product

Resources

About